4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy
November 18, 2024 08:00 ET
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and...
4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy
November 18, 2024 02:00 ET
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and...
4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED
November 14, 2024 08:00 ET
|
4Bio Capital
Press Release 4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED 4BIO Capital named as the first and only UK-based venture fund to be accredited by the Japan Agency for Medical...
4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED
November 14, 2024 03:00 ET
|
4Bio Capital
Press Release 4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED 4BIO Capital named as the first and only UK-based venture fund to be accredited by the Japan Agency for Medical...
11x Raises a $50 Million Series B Led by Andreessen Horowitz to Accelerate the Era of Digital Workers
November 11, 2024 12:00 ET
|
11X AI INC.
SAN FRANCISCO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- 11x, the leader in AI-powered digital workers for revenue teams, today announced the closing of a $50 million Series B funding round led by...
SuRo Capital Corp. Reports Third Quarter 2024 Financial Results
November 07, 2024 16:05 ET
|
SuRo Capital Corp.
Continues to Advance AI Strategy with Major New Investments Net Asset Value of $6.73 Per Share as of September 30, 2024 NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- SuRo...
4BIO Capital Strengthens Investment Team
November 04, 2024 08:00 ET
|
4Bio Capital
Press Release LONDON, 4 November 2024 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm focused solely on the advanced and emerging therapies sector, announces today the...
Climate Tech VC Cerulean Ventures to Hold Biodiversity Roundtable during UN Biodiversity COP 16, Cali, Colombia
October 21, 2024 16:20 ET
|
Cerulean Ventures, LLC
Cerulean Ventures, a climate tech venture capital investing in nature-tech and biodiversity, will hold a roundtable discussion during Bloom 24 at UN COP 16
Aeroflow Health Launches Venture Arm; Co-Leads $3.7 Million Seed Round for Canopie
September 19, 2024 08:00 ET
|
Aeroflow Health
ASHEVILLE, N.C., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Aeroflow Health, a pioneering healthcare company that leverages cutting-edge technology to support the delivery of medical products and services,...
11x Secures $24 Million Series A Funding Led by Benchmark to Create the Future of Digital Work
September 16, 2024 12:00 ET
|
11X AI INC.
11x secures $24 million Series A funding led by Benchmark to create the future of digital work.